Yeon-su Lee

Title: Yeon-su Lee: Innovator in Genetic Amplification Technologies

Introduction

Yeon-su Lee is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of genetic amplification technologies, particularly in the development of multiplex PCR primer sets. With a total of 2 patents, his work has the potential to impact the diagnosis and understanding of diabetes-related genetic conditions.

Latest Patents

Yeon-su Lee's latest patents include a multiplex PCR primer set for human HNF-1α gene amplification. This invention provides a primer pool designed to amplify a target sequence of the human HNF-1α gene with high specificity, speed, sensitivity, and low cost. This technology is particularly useful for detecting maturity-onset diabetes of the young (MODY) 3 associated gene. Another notable patent is the multiplex PCR primer set for human glucokinase gene amplification. This invention also includes a primer pool that allows for the amplification of the human glucokinase gene, facilitating the detection of MODY 2 associated gene with similar advantages.

Career Highlights

Yeon-su Lee is currently employed at Samsung Electronics Co., Ltd., where he continues to innovate in the field of genetic research. His work at this leading technology company allows him to collaborate with other experts and contribute to advancements in health-related technologies.

Collaborations

Some of Yeon-su Lee's notable coworkers include Mi-Kyung Kim and Jung-nam Lee. Their collaborative efforts enhance the research and development of genetic amplification technologies.

Conclusion

Yeon-su Lee's contributions to genetic amplification technologies through his innovative patents demonstrate his commitment to advancing medical diagnostics. His work at Samsung Electronics Co., Ltd. positions him as a key player in the field, and his collaborations further strengthen the impact of his inventions.